INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Home Depot, Inc. – HD

NEW YORK CITY, NY / ACCESS Newswire / December 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The Home Depot, Inc. ("Home Depot" or the "Company") (NYSE:HD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Home Depot and certain of […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CoreWeave, Inc. – CRWV

NEW YORK CITY, NY / ACCESS Newswire / December 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CoreWeave, Inc. ("CoreWeave" or the "Company") (NASDAQ:CRWV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CoreWeave and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Logitech International S.A. – LOGI

NEW YORK CITY, NY / ACCESS Newswire / December 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Logitech International S.A. ("Logitech" or the "Company") (NASDAQ:LOGI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Logitech and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. – PETS

NEW YORK CITY, NY / ACCESS Newswire / December 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PetMed and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gauzy Ltd. – GAUZ

NEW YORK CITY, NY / ACCESS Newswire / December 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Gauzy Ltd. ("Gauzy" or the "Company") (NASDAQ:GAUZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Gauzy and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VirTra, Inc. – VTSI

NEW YORK CITY, NY / ACCESS Newswire / December 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of VirTra, Inc. ("VirTra" or the "Company") (NASDAQ:VTSI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether VirTra and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savers Value Village, Inc. – SVV

NEW YORK CITY, NY / ACCESS Newswire / December 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Savers Value Village, Inc. ("Savers" or the "Company") (NYSE:SVV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Savers and certain of its officers

The 4th China International Supply Chain Expo Set for Beijing in June 2026

Sustained Worldwide Outreach Drives Greater Collaboration Opportunities The 4th China International Supply Chain Expo (“CISCE,” “the Expo”) will be held in Beijing from June 22 to 26, 2026. To date, more than 300 companies have signed up to exhibit, with preparations moving forward smoothly. https://mma.prnewswire.com/media/2840070/WechatIMG2165.jpg From November 30 to December 2, a delegation of Chinese

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition

— R289 continues to be generally well tolerated and at doses of ≥500 mg QD preliminary efficacy was observed in elderly, heavily pre-treated lower-risk MDS patients — RBC-TI was achieved by 33% (6/18) of evaluable transfusion dependent patients receiving R289 doses ≥500 mg QD, including 40% (2/5) in the 500 mg BID dose group Rigel

Nayax Considering an Offering of Notes and Warrants in Israel

(NASDAQ:NYAX),(TASE:NYAX),(TASE:NYAX.TA), HERZLIYA, Israel, Dec. 07, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX) (the “Company”), a global commerce payments and loyalty platform designed to help merchants scale their business, announced today that it is considering an offering by way of an expansion of its existing Series A Notes and Series 1 Warrants, with

Scroll to Top